{"id":1271,"date":"2025-10-16T10:44:49","date_gmt":"2025-10-16T10:44:49","guid":{"rendered":"https:\/\/internationalforum.bmj.com\/oslo\/?p=1271"},"modified":"2026-04-23T06:00:28","modified_gmt":"2026-04-23T06:00:28","slug":"anna-birna-almarsdottir","status":"publish","type":"post","link":"https:\/\/internationalforum.bmj.com\/oslo\/2025\/10\/16\/anna-birna-almarsdottir\/","title":{"rendered":"Anna Birna Almarsd\u00f3ttir"},"content":{"rendered":"<br><p><em><strong>University of Copenhagen; Denmark<\/strong><\/em><\/p><br><p><span data-sheets-root=\"1\">Professor Almarsd\u00f3ttir received her Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill and is trained as a pharmacist in Iceland. She is currently Professor of Social and Clinical Pharmacy (part-time) in the Research group for Social and Clinical Pharmacy, University of Copenhagen (https:\/\/pharmacy.ku.dk\/research\/social-clinical-pharmacy\/), Denmark. The group is designated a WHO Collaborating center for Research and Training in the Patient Perspective on Medicines Use (https:\/\/whocc-meduse.ku.dk\/). The group is a world leader of research \u201con\u201d and \u201cwith\u201d patients regarding medicines use. Her research interests include pharmaceutical policy analysis, developing new clinical pharmacy services, and patient involvement in drug therapy decision-making. Currently, she manages the awareness campaign Sof\u00f0uvel in Iceland, using a Patient\/Public Engagement approach where she engages representatives of older persons in the design, implementation and evaluation of the initiative.<br><\/span><\/p><br>","protected":false},"excerpt":{"rendered":"<p>University of Copenhagen; DenmarkProfessor Almarsd\u00f3ttir received her Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill and is trained as a pharmacist in Iceland. She is currently Professor of Social and Clinical Pharmacy (part-time) in the Research group for Social and Clinical Pharmacy, University of Copenhagen (https:\/\/pharmacy.ku.dk\/research\/social-clinical-pharmacy\/), Denmark. The [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1271","post","type-post","status-publish","format-standard","hentry","category-speaker"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/posts\/1271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/comments?post=1271"}],"version-history":[{"count":0,"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/posts\/1271\/revisions"}],"wp:attachment":[{"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/media?parent=1271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/categories?post=1271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/oslo\/wp-json\/wp\/v2\/tags?post=1271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}